Literature DB >> 11520363

A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment.

K Narayan1, R J Hicks, T Jobling, D Bernshaw, A F McKenzie.   

Abstract

The aim of this study was to assess whether positron emission tomography (PET) or magnetic resonance imaging (MRI) could obviate the need for surgical staging in patients with locally advanced cervical carcinoma being planned for radiotherapy (RT). Imaging findings were compared to surgical staging in 27 patients including three with recent resection of the primary tumor. Both PET and MRI visualized all 24 residual cervical tumors. Primary tumor volume, as measured by MRI scan, ranged from 1.25 cc to 140 cc. In 24 patients evaluable for pelvic nodal status, PET had sensitivity, specificity, and positive and negative predictive values of 83%, 92%, 91% and 85%, respectively, with 88% accuracy. MRI detected only six in 12 (50%) patients with confirmed pelvic nodal disease, all of which were also seen by CT and PET, with an overall accuracy of 75%. PET detected only four in seven (57%) cases with confirmed para-aortic (PA) involvement. All histologically confirmed sites not visualized on PET were <1 cm. Without surgical staging, six in 10 (60%) patients with histologically proven pelvic nodal disease would not have received pelvic boost if guided by MRI alone, compared to two in 10 (20%) patients guided by PET alone or in combination with MRI. All four patients with positive PA on PET were confirmed on histology or clinical follow-up, including one case that proved to be a false negative one on surgery. However, in three cases, PET would have yielded an inadequate radiation volume. In conclusion, the positive predictive value of PET in the pelvis and para-aortic region appears sufficient to obviate lymph nodal sampling, but sampling is still required to exclude small-volume disease cranial to sites of abnormality on PET. MRI has insufficient accuracy for nodal staging to impact management.

Entities:  

Mesh:

Year:  2001        PMID: 11520363     DOI: 10.1046/j.1525-1438.2001.011004263.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  12 in total

Review 1.  The role of imaging in the management of non-metastatic cervical cancer.

Authors:  Orit Kaidar-Person; Roxolyana Bortnyak-Abdah; Amnon Amit; Alison Berniger; Rahamim Ben-Yosef; Abraham Kuten
Journal:  Med Oncol       Date:  2012-04-25       Impact factor: 3.064

2.  Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.

Authors:  Lisa A Min; Wouter V Vogel; Max J Lahaye; Monique Maas; Maarten L Donswijk; Erik Vegt; Miranda Kusters; Henry J Zijlmans; Katarzyna Jóźwiak; Sander Roberti; Regina G H Beets-Tan; Doenja M J Lambregts
Journal:  Eur Radiol       Date:  2019-05-22       Impact factor: 5.315

3.  Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer.

Authors:  Hiral P Fontanilla; Ann H Klopp; Mary E Lindberg; Anuja Jhingran; Patrick Kelly; Vinita Takiar; Revathy B Iyer; Charles F Levenback; Yongbin Zhang; Lei Dong; Patricia J Eifel
Journal:  Pract Radiat Oncol       Date:  2012-03-30

4.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

5.  Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.

Authors:  Vinita Takiar; Hiral P Fontanilla; Patricia J Eifel; Anuja Jhingran; Patrick Kelly; Revathy B Iyer; Charles F Levenback; Yongbin Zhang; Lei Dong; Ann Klopp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-01-17       Impact factor: 7.038

6.  The role of PET/CT in cervical cancer.

Authors:  Fernanda G Herrera; John O Prior
Journal:  Front Oncol       Date:  2013-02-26       Impact factor: 6.244

Review 7.  The role of FDG-PET/CT in gynaecological cancers.

Authors:  Andrea G Rockall; Susan Cross; Sean Flanagan; Elizabeth Moore; Norbert Avril
Journal:  Cancer Imaging       Date:  2012-03-05       Impact factor: 3.909

8.  Role of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence in patients with cervical cancer.

Authors:  Amit Bhoil; Bhagwant Rai Mittal; Anish Bhattacharya; Sampath Santhosh; Firuza Patel
Journal:  Indian J Nucl Med       Date:  2013-10

9.  A Network Meta-Analysis on the Diagnostic Value of Different Imaging Methods for Lymph Node Metastases in Patients With Cervical Cancer.

Authors:  Qian Luo; Lan Luo; Liang Tang
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

10.  IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.

Authors:  Zoltán Lőcsei; Klára Sebestyén; Zsolt Sebestyén; Eszter Fehér; Dorottya Soltész; Zoltán Musch; László Csaba Mangel
Journal:  Pathol Oncol Res       Date:  2021-03-24       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.